Canax

About:

biotech company specialized on CO2 supercritical extraction of Cannabis, CBD and natural active substances

Description:

CO2 extraction specialist, to accelerate and support the world's transition from synthetic therapy into Cannabis derived pharmaceutical solution, and the integration of Cannabis, Hemp, and other plant derived extracts into the day-to-day life.

Total Funding Amount:

2.5M EUR

Headquarters Location:

Milan, Lombardia, Italy

Founded Date:

2019-04-19

Contact Email:

info(AT)canax.com

Founders:

Fabrizio Faion

Number of Employees:

1-10

Last Funding Date:

2022-03-16

IPO Status:

Private

Industries: